Business Today US India IPR FDA Pharma Sector
Alchemy by E Kumar Sharma
USFDA commissioner's comments raise new hopes for Indian pharma

There have been fresh concerns related to the transition to a Goods and Services Tax (GST) regime. Then, the industry lost one of its leaders - Desh Bandhu Gupta, the 79-year-old founder and chairman of Lupin.

 
 
High profile investment melas by Indian states, backed by big numbers to showcase potential investor interest, are par-for-the-course today.
Water, as things stand today, is a state subject even though ground water management is a national priority.
Global drug development history has its examples of instances where red flags were raised, which later turned out to be red herrings.
 
 
But then, there are few questions that need to be addressed to ensure the move leads to maximum benefit for the patients.
UK-based pharma company GlaxoSmithKline and one of the oldest pharma MNC in India, has announced that it will not file for patents in the low income countries.
The passing away of P. Ravindra Reddy, Founder Chairman of Hyderabad-based MTAR Technologies, marks more than an end to an eventful journey.
Advertisement